Presentation Information
[P3-14]Survey on toxicokinetics guidance (ICH-S3A guideline): Current landscape and challenges faced by pharmaceutical companies
*Takuya Kuno1, Ryota Higuchi1, Tomoyuki Kishida1, Yuko Itsuji1, Mami Kamada1, Takaaki Tanabe1, Yuki Inoue1, Mutsumi Suzuki1 (1. Non-Clinical Evaluation Expert Committee, Drug Evaluation Committee, Japan Pharmaceutical Manufacturers Association)
Keywords:
toxicokinetics,guideline,microsampling
Password required to view
Log in
or
Comment
To browse or post comments, you must log in.Log in